Premium
O2‐02‐06: CEREBROSPINAL‐FLUID‐BASED BIOMARKER EVIDENCE OF AMYLOIDOGENESIS IN DEMENTIA WITH LEWY BODIES DEPENDS UPON APOE ‐ε4 CARRIER STATUS
Author(s) -
Ferreira de Oliveira Fabricio,
Miraldo Marjorie Câmara,
Castro-Neto Eduardo Ferreira,
Machado Fernando Chiodini,
Soares de Almeida Sandro,
Luiz de Andrade Matas Sandro,
Ferreira Bertolucci Paulo Henrique,
Graça Naffah-Mazzacoratti Maria
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.4462
Subject(s) - dementia with lewy bodies , apolipoprotein e , clinical dementia rating , dementia , medicine , cerebrospinal fluid , biomarker , frontotemporal dementia , amyloid (mycology) , psychology , pathology , psychiatry , endocrinology , gastroenterology , oncology , chemistry , disease , biochemistry